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Abstract 
Introduction: Cerebral venous thrombosis, 
including thrombosis of cerebral veins and 
major dural sinuses, is an uncommon 
disorder in the general population. 
However, it has a higher frequency among 
patients younger than 40 years old, patients 
with thrombophilia, and women who are 
pregnant or receiving hormonal 
contraception. The annual incidence is 
estimated to be 3 to 4 cases per million. 
Coexisting cerebral vein thrombosis and 
aneurysmal disease in the setting of acute 
subarachnoid hemorrhage is exceedingly 
rare. These rare situations put difficult 
problems of diagnosis and treatment. 
Case Report: We present the case of a 42-
year-old man patient who was diagnosed 
with thrombophilia of heterozygous factor 
V Leiden mutation and right ischemic 
stroke internal carotid cerebral artery four 
years ago. The patient presented with 
nausea, vomiting, a progressive severe 
headache that had lasted for a few days, 
followed by a rapid deterioration in the 
level of consciousness.On admission, the 
patient was in a comatose state, GCS score 
5, mydriasis with bilaterally preservation of 
fotomotor reflex, stiff neck, acute 
respiratory failure and vegetative disorder. 
Cerebral CT scan showed a acute 
tetraventricular hydrocephalus and 
subarachnoid hemorrhage and cerebral four 
vessels angiography showed an left 
posterior communicating artery aneurysms 
and complete occlusion of right internal 
carotid artery.The aneurysm was managed 
with endovascular coiling with 100% 
occlusion achieved and acute 
hydrocephalus was treated first with 
external ventricular drainage and in a 
second time with ventriculoperitoneal 
shunt.The immediate and late outcome of 
patient has been addicted to several 
complications: acute bacterial meningitis, 
left hemiparesis, bronchopneumonia, 
urinary infection, malfunction of external 
ventricular drainage end swallowing 
disorders. 
Conclusion: In this report, the authors 
discuss the case of a coexistence ruptured 
aneurysm of the left posterior 
communicating artery in one patient 
known with factor V Leiden thrombophilia 
and proximal right ICA occlusion.This 
associated is more rare and dangerous, but 
curable disease. The case clearly illustrates 
both the difficulty in establishing the cause 
of subarachnoid hemorrhage in the 
presence of both aneurismal and CVST 
disease as well as the initiation of post-
endovascular coil embolization 
anticoagulation therapy. Endovascular coil 
embolization of the aneurysm was thus 
undertaken, with subsequent heparin 
anticoagulation to attempt to prevent 
 
 
 
Romanian Neurosurgery (2013) XX 2: 170 – 179          171 
 
 
 
thrombus propagation.This neurosurgical 
strategy for treatment of a patient 
conducted to excellent results.  
Key words: thrombophilia, factor V 
Leiden mutation, subarachnoid 
hemorrhage, cerebral aneurysms. 
Introduction 
Coexisting cerebral vein thrombosis and 
aneurysmal disease in the setting of acute 
subarachnoid hemorrhage is very rare. 
Clinical management of the patient is such 
an instance is difficult (11). The evolution 
of noninvasive diagnostic imaging 
methodologies such as CT angiography and 
venography, as well as MR imaging, 
angiography, and venography (16), 
cultivated our knowledge regarding the full 
clinical spectrum of CVST (1). Cerebral 
venous sinus thrombosis justifies for 0.5% 
of all stroke cases (5). The incidence of 
CVST, in adults has been estimated to be as 
3–4 cases per million people (1).One of the 
causes of these disorders is factor V Leiden. 
Factor V Leiden thrombophilia is an 
hereditary disorder, mutation, of the 
mechanisms of blood clotting.The 
frequency of factor V Leiden and its 
prevalence in thromboembolic disease 
emphasize the need for nursing 
professionals to better understand the 
consequences of the factor V Leiden 
mutation (14). 
Determining the aetiology of the 
subarachnoid bleed is important for 
determines the treatment strategy; 
especially the initiation of anticoagulation 
therapy balancing the risk of 
thromboembolism with further 
hemorrhage (7).The morbidity and 
mortality in such cases may be predictably 
high. 
We describe a case and discuss the basis 
of the management strategy in a patient 
who presents in this setting. Proximal right 
ICA occlusion shows abnormal collateral 
vascular networks from posterior 
circulation and accompanying saccular 
aneurysms. The left posterior 
communicating artery aneurysm associated 
with proximal right ICA occlusion in one 
patient with factor V Leiden thrombophilia 
is more rare and dangerous, but curable 
disease. Endovascular embolization for such 
aneurysms is safe and available. 
Case report 
M.G.E., 42 y.o. man, was admitted into 
the Neurosurgical Department, Intensive 
Care Department from the Emergency 
Clinical Hospital “Prof. Dr. N. Oblu” Iasi, 
Romania. At admission the patient was 
comatose, GCS (Glasgow Coma Scale) 
score 5, mydriasis with bilaterally 
preservation of fotomotor reflex, stiffness 
neck, acute respiratory failure and 
vegetative disorder. Family reported that 
the last 24 hours the patient had headache, 
nausea and vomiting. He had a history of 
hypertension that was not being treated, 
smoking and also the patient was diagnosed 
with thrombophilia of heterozygous factor 
V Leiden mutation, right ischemic stroke 
internal carotid cerebral artery four years 
ago. The patient subsequently made an 
unremarkable recovery with no 
neurological deficit. The past three years 
the patient did not follow any treatment. 
In our institution he was evaluated after 
admission with cerebral computed 
tomography scan (CT scan) (figures 1, 2, 3 
and 4), cerebral computed tomography 
angiography (CTA) and basic evaluation for 
general health problems blood (tests, EKG, 
chest x-ray, cardiologic evaluation). 
Neurological exam on admission 
revealed comatose state, GCS score 5, left 
hemiparesis, flexion of right limbs on 
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noxious stimuli, Babinsky’s sign at the right 
foot and absent cutaneous plantar response 
at the right foot, neck stiffness. 
A coagulopathy screen was negative. The 
prothrombin time (PT) was 14.0/sec, 
international normalized ratio (INR) was 
1.1 and Platelets (PLT)=265.000/mm. 
Brain computed tomography (figures 1, 2, 3 
and 4) shows a acute tetraventricular 
hydrocephalus and subarachnoid 
hemorrhage. 
 
 
Figure 1 
 
 
Figure 2 
The cerebral computed tomography 
angiography (CTA) shows acute 
tetraventricular hydrocephalus and 
subarachnoid hemorrhage, without viewing 
right internal jugular vein in the jugular 
foramen, right transverse sinus and 
sigmoid, right ICA thrombosis, right 
segment M1 amputeted of 1 cm from the 
origin, segmental thrombosis of the left 
ICA supracavernos segment, then visualize 
hypoplastic left A1 segment. 
 
 
Figure 3 
 
 
Figure 4 
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Figure 5 
 
 
Figure 6 
 
In emergency was insert a external 
ventricular drainage (figures 5 and 6). 
The patient’s evolution has been very 
difficult with multiple complications: acute 
bacterial meningitis, left hemiparesis, 
bronchopneumonia, urinary infection, 
malfunction of external ventricular drainage 
end swallowing disorders. 
 
 
In the tenth day postoperative the patient 
had fever 37, 8 C, and examination of 
cerebrospinal fluid showed 6830 leukocytes 
and 4270 erythrocytes. The etiology of 
bacterial meningitis was Staphylococcus 
aureus and we started the treatment with 
antibiotics.  
After 14 days with antibiotics the 
examination of cerebrospinal fluid showed 
11 leukocyte and the patient don’t have 
fever. Because of many complications the 
ventriculoperitoneal (VP) shunt was 
inserted after 27 days of admission in 
hospital. 
Treatment was following the directions 
of identifying and eliminating the 
precipitating factor, anticoagulation 
administration, and aggressive intracranial 
hypertension management and 
anticonvulsive treatment.  
The cerebral four vessels angiography 
showed an left posterior communicating 
artery aneurysm (figure 7) and complete 
occlusion of right internal carotid artery 
(figure 9) with no anterograde flow across 
of this occlusion (figure 10). 
The procedure was perform with the 
patient under general anesthesia. The 
femoral access was with a 5F vascular 
sheath and femoral catheterization was 
done with a 5F guiding catheter. A 5F 
guiding catheter was introduce into the 
proximal parent artery at which the target 
aneurysmal lesion was locate. Excelsior SL 
10 microcatheter was ascend on 
miccroguiding. Have been introduced and 
detached two spiral coils GDC -10 and one 
spiral Axium, which achieved a sufficient 
compaction aneurysm occlusion without 
filling the residual. Figure 11 and figure 12 
show the alimentation to the system 
anterior cerebral and right medium cerebral 
from vertebrobasilar system. 
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Figure 7 
 
 
Figure 8 
 
 
Figure 9 
 
 
Figure 10 
 
 
Figure 11 
 
 
Figure 12 
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Endovascular coil embolization of the 
aneurysm was thus undertaken (figure 7: 
preembolization and figure 8: post-
embolization) with subsequent heparin 
anticoagulation to attempt to prevent 
thrombus propagation. The optimal 
treatment of CVST remains controversial 
partly due to the variable nature of disease 
progression, further complicating the 
management of such patients(16). 
Heparinisation was reversed after our 
patient acutely deteriorated, but 
subsequently made an uneventful recovery. 
Discussion 
Both intracranial aneurysms and cerebral 
venous sinus thrombosis are acknowledged 
causes of subarachnoid hemorrhage (SAH) 
(32). Spontaneous SAH is related to a 
ruptured aneurysm in 85% of cases. All the 
same, SAH can even present as the initial 
manifestation of cerebral venous sinus 
thrombosis (CVST). In most of such cases 
the distribution of SAH is over the cortical 
surface of the brain, typically associated 
with a cortical venous infarction which may 
or may not be hemorrhagic. The venous 
hemorrhagic infarction is responsible for 
the production of SAH by secondary 
rupture into the subarachnoid space and the 
mechanism of CVST with secondary 
venous hypertension resulting in the 
rupture of fragile, thin-walled cortical veins 
has been proposed (5). It is important to 
look for the presence of venous thrombosis 
on a CTA, particularly if the SAH is over 
the cortical surface. 
When intracranial aneurysms and 
cerebral venous sinus thrombosis coexist in 
an acute SAH, the established cause will 
determine firstly the necessity and urgency 
in treating the aneurysm and secondly, 
treatment of the venous thrombosis by 
anticoagulation to prevent clot propagation 
or rarely clot thrombolysis (7). Despite 
both the aneurysm and CVST occurring on 
the same side as the bleed, the pattern of 
distribution of blood made acute aneurysm 
rupture most likely in our patient. 
Thrombophilia with a factor V Leiden 
mutation was a possible risk factor for 
developing CVST in our patient. In factor 
V Leiden, patients have a point mutation in 
the factor V gene that produces a mutated 
factor V. The factor V Leiden is inactivated, 
on the clotting level, about 10 times slower 
than normal factor V and persists longer in 
the circulation, resulting in increased 
generation of thrombin and a 
hypercoagulable state (thrombophilia). In a 
factor V Leiden the INR and PTT are 
normal, because the patient with factor V 
Leiden makes fibrin at the same rate as a 
person with normal factor V.  
Two distinct pathophysiological theories 
have been developed for explaining the 
clinical presentation of CVST (24).The first 
theory postulates that the thrombosis of the 
cerebral veins or sinuses can result in 
increased venular and capillary pressure 
who contributes to parenchymal 
hemorrhage, vasogenic and cytotoxic 
edema; and the second pathophysiological 
mechanism theory relies on the direct 
thrombosis of major cerebral venous 
sinuses (24). The resulting higher pressure 
of the thrombosed sinuses impedes the 
absorption and the circulation of the 
cerebrospinal fluid (CSF) from the 
subarachnoid space to the cerebral venous 
circulation via the arachnoid villi structures 
and the impairment of CSF absorption 
conducts to the development of intracranial 
hypertension.The raised intracranial 
pressure resulting from venous thrombosis 
has been postulated to cause venous 
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dilatation with subsequent rupture or 
aneurysmal rupture (4); the latter remains a 
possible aetiological factor in our patient. 
It is known that the most important 
etiological factor for intracranial saccular 
aneurysm is hemodynamic stress. The 
occlusion of one or more feeding vessels 
may enhance the possibility of aneurysm 
formation at large arterial forks subjected to 
increased hemodynamic stress associated 
with collateral flow(18). Formation of new 
aneurysms is a potential complication in the 
management of patients following ICA 
occlusion and the data reviewed here 
suggest that “de novo aneurysm formation 
occurs in 4.3% of patients undergoing 
vessel occlusion at an average of 9 years 
following the occlusion” (25). The 
pathogenesis is not clear, one hypothesis 
relates to hemodynamic stress. Like in our 
case the vessels are subject to increased 
blood flow to supply the contralateral 
circulation, following ICA occlusion. This 
may give rise to degeneration of the 
endothelial basement membranes and 
subendothelial connective tissue of the 
arterial wall. Besides, previous literature 
suggests that the risk factors predictive of 
initial aneurysm formation likely correlate 
with de novo formation. The factors 
predictive include history of arterial 
hypertension, cigarette smoking, female 
gender, age, history of multiple and familial 
forms of intracranial aneurysms, and 
hereditary connective tissue diseases (15, 
17, 19).The location of de novo aneurysms 
observed is likely multifactorial due to an 
underlying diathesis of the vessel to 
aneurysm formation as well as changes in 
flow. The patients with ICA occlusion 
should receive continued radiographic 
follow-up imaging, such as CTA and MRA 
and this follow-up is especially important in 
the first decade (25). 
Symptomatic formation and/or 
enlargement of aneurysms as a late 
complication of internal carotid artery 
occlusion has been slightly reported (23). A 
review of the literature in 1989 by Dyste 
and Beck reported an incidence of 
symptomatic aneurysm formation between 
4% and 10%(6). On of the role in the 
formation and/or enlargement of these 
aneurysms plays a hemodynamic case (6, 8, 
13). 
The extensive collateral networks as well 
as the already compromised cerebral blood 
flow and high internal blood pressure 
makes the direct clipping for these 
aneurysms to be difficult and the morbidity 
is high (28). With endovascular techniques, 
the aneurysms that are difficult to reach by 
craniotomy can now be treated with 
excellent results. Conservative management 
for these aneurysms can lead to dismal 
results and aggressive treatments should be 
considered. We chose this procedure and 
endovascular coil embolization of the 
aneurysm was thus undertaken, with 
subsequent heparin anticoagulation to 
attempt to prevent thrombus propagation.  
The treatment of patients with CVST 
should follow 4 directions to provide a 
complete treatment plan and maximize the 
chance of favorable outcome. All stages 
should be include to identify and 
appropriately manage the predisposing and 
precipitating factors, administer 
antithrombotic therapy, lower and 
normalize the elevated ICP, and provide 
symptomatic treatment for seizures, 
headache, and visual disturbances (31). 
Treatment of CVST with 
anticoagulation (AC) is recommended, 
even if the evidence for its benefit is not 
substantial (29). For all that, AC for CVST 
 
 
 
Romanian Neurosurgery (2013) XX 2: 170 – 179          177 
 
 
 
continues to be beneficial even in the 
presence of ICH (18), the optimum time to 
start such a treatment option has not been 
clearly defined. We report a case of CVST 
with SAH, who responded favorably to AC. 
The most neurologists currently start 
treatment with heparin as soon as the 
diagnosis is confirmed, even in the presence 
of hemorrhagic complications (29). 
Heparin treatment has been shown to be 
beneficial rather than dangeroust when 
CVST is associated with ICH. In 43 
patients with CVST and ICH, Einhäupl et 
al. (10) reported a mortality of 15% in 
heparin-treated patients compared to 69% 
that in those who did not receive heparin. 
In our case, AC therapy was associated with 
a favorable outcome.The safety of 
immediate AC with cases of SAH and 
CVST upon presentation needs further 
clarification as in most of the reported cases 
of CVST with ICH, heparin treatment was 
delayed (10, 21). Oppenheim et al. 
suggested performing magnetic resonance 
angiography or digital subtraction 
angiography, to rule out intracranial 
aneurysm before AC in cases of CVST with 
SAH (21). The mean delay between the 
onset of symptoms and heparin treatment 
was 33 days in the study by Einhäupl et al. 
(10). To evaluate the time interval when 
enlargement of venous intracerebral 
hemorrhages is more likely to occur, no 
studies were found. In general, active 
bleeding into the brain is usually confined 
to the first 6 h following ICH, with 10–15% 
of patients showing hematoma enlargement 
between 6 and 24 h from the onset of 
spontaneous ICH (12). 
Evidence suggests that the hemodynamic 
changes secondary to occlusion of feeding 
arteries, like was in our case, may lead to 
compensatory changes in the blood flow 
through anastomotic vessels (22, 26). The 
formation of an aneurysm is starts with the 
increase in blood flow and change in 
velocity, through these smaller vessels can 
increase the pressure on the arterial wall, 
facilitate weakening and promote 
remodeling (27, 30). 
In our review of the literature, we found 
that collateral circulation most commonly 
arises from the vertebrobasilar system and 
the most frequent location of aneurysms are 
the basilar and posterior cerebral arteries. 
The direction of the aneurysm sac (as in 
our case) confirms that the aneurysm 
formation was induced by hemodynamic 
modifications. Saccular aneurysms 
associated with carotid artery occlusion, as 
with other arterial anomalies, have a high 
tendency to bleed because of the increased 
blood flow in the parent arterial system. 
These patients are at a higher risk of 
complications related to either modality of 
intervention because of parent 
malformation (28). 
Conclusion 
Our case clearly illustrates both the 
difficulty in establishing the cause of 
subarachnoid hemorrhage in the presence 
of both aneurismal and CVST disease as 
well as the initiation of post-endovascular 
coil embolization anticoagulation therapy. 
Based on our case and selected cases in the 
literature, it would appear that instigating 
anticoagulation treatment with subsequent 
close clinical, imaging and transcranial 
pressure monitoring is to be advocated. 
Early diagnosis of CVST is crucial and 
constitutes our first target in treating our 
patients with suspected CVST. In the cases 
in which the diagnosis of CVST is 
confirmed by clinical data and 
neuroimaging studies, our next step is the 
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identification of the underlying cause. 
Every directions is made in the prophylaxis 
and symptomatic treatment of seizures, 
intracranial hypertension, headache, and/or 
visual disturbances. 
The basis of CVST treatment is proper 
anticoagulation in the acute setting. The 
EFNS guidelines involves the use of 
intravenous heparin or subcutaneous 
LMWH. Transient causes of CVST are 
usually treated in our institution with 3-
month oral anticoagulation therapy, 
patients with CVST due to mild 
thrombophilias usually take the proper dose 
of oral anticoagulation for 6–12 months, 
and patients with severe thrombophilias 
require lifetime treatment. AC treatment 
for cases of CVST with hemorrhagic 
complications was not associated with 
adverse outcome. If ICH is present, 
immediate AC for CVST at presentation 
and within 24 h from onset of symptoms 
cannot be safely recommended, as in almost 
all previous reports there was a delay in the 
onset of AC ranging between 4 and 33 days. 
We also recommend to perform magnetic 
resonance angiography or digital 
subtraction angiography before AC in cases 
of CVST with SAH to rule out a coincident 
intracranial aneurysm. 
Endovascular embolization may be a 
good treatment option with excellent safety 
for a ruptured aneurysm that accompanies 
proximal ICA occlusion with vulnerable 
collateral flow. It’s a technical challenge 
with an endovascular procedure for to 
access to the saccular segment of left 
posterior communicating artery, because to 
the longer navigation route and its impact 
on the stability of catheter guidance systems 
currently available. However, this may 
involve a major risk of thromboembolic 
complications during and after the 
procedure, because of delivery and stability. 
For these we need a high level of technical 
expertise. The possible existence of such 
angioarchitectural arrangement will prompt 
early diagnosis. Because the risks of 
rebleeding remains a major killer in the 
natural course of the disease, an 
interventional procedure with an optimal 
risk-benefit equation is yet to be 
determined for these patients. 
Hemodynamic factors are commonly 
believed to play an important role in the 
pathogenesis, progression, and rupture of 
cerebral aneurysms. Recent studies have 
hypothesized that hemodynamic changes in 
parent vessels are responsible for the 
formation of cerebral aneurysms. We 
conclude that the regression and potentially 
the formation of this aneurysm is correlated 
with hemodynamic factors associated with 
occlusion of the contralateral ICA and the 
arteriographic evaluation is indicated in 
every patient in whom carotid artery 
occlusion, so that preexisting aneurysms 
may be found and treated. 
 The treatment of patients with CVST 
coexist with intracranial aneurysm usually 
requires a multidisciplinary approach, 
including specialists and close collaboration 
between the departments of hematology, 
neurology, neurosurgery, neuro-
interventional surgery and neurointensive 
care. 
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